COMMODORE CAPITAL LP's Q3 2026 13F: 11 new positions, 7 exits
Form 13F-HR for the quarter ended Sep 30, 2026 · filed Nov 16, 2026 · 37 reported positions · accession 0001831942-26-000052
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Reduced | AMYLYX PHARMACEUTICALS INC (AMLX) | 6.0% | 4.5% | −1.5 pts | −3.65M sh | −65% |
| Reduced | COGENT BIOSCIENCES INC (COGT) | 7.0% | 3.1% | −3.9 pts | −1.79M sh | −59% |
| Exited | TANGO THERAPEUTICS INC (TNGX) | 4.2% | — | −4.2 pts | −2.25M sh | −100% |
| Exited | EYEPOINT INC (EYPT) | 3.9% | — | −3.9 pts | −4.6M sh | −100% |
| Reduced | DEFINIUM THERAPEUTICS INC (DFTX) | 5.6% | 2.1% | −3.5 pts | −1.3M sh | −65% |
| New | DAMORA THERAPEUTICS INC (DMRA) | — | 3.2% | +3.2 pts | +1.94M sh | new |
| Exited | DAMORA THERAPEUTICS INC (GLTO) | 3.0% | — | −3.0 pts | −1.94M sh | −100% |
| New | SURROZEN INC (SRZN) | — | 2.2% | +2.2 pts | +885K sh | new |
| New | KORSANA BIOSCIENCES INC (KRSA) | — | 2.2% | +2.2 pts | +877K sh | new |
| New | SAGIMET BIOSCIENCES INC (SGMT) | — | 2.1% | +2.1 pts | +2.76M sh | new |
| New | ADARX PHARMACEUTICALS INC (ADRX) | — | 1.9% | +1.9 pts | +1.26M sh | new |
| Reduced | ASSEMBLY BIOSCIENCES INC (ASMB) | 2.3% | 0.8% | −1.5 pts | −953K sh | −67% |
| New | ENTERA BIO LTD (ENTX) | — | 1.7% | +1.7 pts | +7.35M sh | new |
| New | ATTOVIA THERAPEUTICS INC (ATTO) | — | 1.5% | +1.5 pts | +1.16M sh | new |
| New | AGENUS INC (AGEN) | — | 1.5% | +1.5 pts | +1.99M sh | new |
| Exited | PERSPECTIVE THERAPEUTICS INC (CATX) | 1.3% | — | −1.3 pts | −6.34M sh | −100% |
| Reduced | PHARVARIS N V (PHVS) | 2.9% | 2.3% | −0.7 pts | −500K sh | −35% |
| Reduced | SPYRE THERAPEUTICS INC (SYRE) | 4.5% | 4.8% | +0.4 pts | −147K sh | −17% |
| Reduced | CELLDEX THERAPEUTICS INC NEW (CLDX) | 3.0% | 2.5% | −0.5 pts | −350K sh | −26% |
| Exited | NUVALENT INC (NUVL) | 0.7% | — | −0.7 pts | −100K sh | −100% |
| Reduced | KYMERA THERAPEUTICS INC (KYMR) | 1.7% | 1.5% | −0.2 pts | −75,000 sh | −30% |
| Reduced | LB PHARMACEUTICALS INC (LBRX) | 2.9% | 3.8% | +0.9 pts | −218K sh | −15% |
| New | RESEARCH ALLIANCE CORP IV (RACD) | — | 0.4% | +0.4 pts | +500K sh | new |
| Reduced | ALKERMES PLC (ALKS) | 9.4% | 9.0% | −0.3 pts | −125K sh | −4% |
| New | JATT III ACQUISITION CORP (JTTT) | — | 0.3% | +0.3 pts | +400K sh | new |
| Exited | RESEARCH ALLIANCE CORP III (RACC) | 0.3% | — | −0.3 pts | −500K sh | −100% |
| New | TCGX ACQUISITION CORP (TCGX) | — | 0.3% | +0.3 pts | +300K sh | new |
| Increased | INFLARX NV (IFRX) | 1.0% | 1.3% | +0.3 pts | +1.97M sh | +27% |
| Increased | RELMADA THERAPEUTICS INC (RLMD) | 0.6% | 0.7% | +0.1 pts | +925K sh | +65% |
| Reduced | TYRA BIOSCIENCES INC (TYRA) | 3.6% | 2.9% | −0.6 pts | −150K sh | −8% |
| Exited | VISTAGEN THERAPEUTICS INC (VTGN) | 0.0% | — | 0.0 pts | −2.79M sh | −100% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 65.2% of the equity book
Changes in the top 10 this quarter: LBRX entered · DMRA entered · TYRA entered · DFTX left · TNGX left · EYPT left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | RELAY THERAPEUTICS INC (RLAY) | 13.4% | 16.8% | |
| 2 | ENLIVEN THERAPEUTICS INC (ELVN) | 9.9% | 11.6% | |
| 3 | ALKERMES PLC (ALKS) | 9.4% | 9.0% | |
| 4 | ALTO NEUROSCIENCE INC (ANRO) | 4.3% | 5.4% | |
| 5 | SPYRE THERAPEUTICS INC (SYRE) | 4.5% | 4.8% | |
| 6 | AMYLYX PHARMACEUTICALS INC (AMLX) | 6.0% | 4.5% | |
| 7 | LB PHARMACEUTICALS INC (LBRX) | 2.9% | 3.8% | Entered the top 10 |
| 8 | DAMORA THERAPEUTICS INC (DMRA) | 0.0% | 3.2% | Entered the top 10 |
| 9 | COGENT BIOSCIENCES INC (COGT) | 7.0% | 3.1% | |
| 10 | TYRA BIOSCIENCES INC (TYRA) | 3.6% | 2.9% | Entered the top 10 |
| — | DEFINIUM THERAPEUTICS INC (DFTX) | 5.6% | 2.1% | Left the top 10 |
| — | TANGO THERAPEUTICS INC (TNGX) | 4.2% | 0.0% | Left the top 10 |
| — | EYEPOINT INC (EYPT) | 3.9% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).